GLP-1s have solidified their place in healthcare as a tool in weight management and, subsequently, the treatment of cardiovascular diseases. The rapidly evolving class of drugs is having a significant impact on cardiovascular service lines, outpatient facilities and other stakeholders…
Cardiology
Medtech company Medtronic has completed its $585 million acquisition of CathWorks, an interventional cardiology medical device company. The deal follows a 2022 strategic partnership between the companies, which included a co-promotion agreement for CathWorks’ FFRangio system in the U.S., Europe…
Harvey Snyder, MD, a pioneering cardiologist, has died at age 75, according to an obituary published in The Philadelphia Inquirer April 21. Dr. Snyder died on April 8, according to the obituary. He served most recently as a longtime trustee…
Whether a surgeon’s sex aligns with that of their patient was ruled out as a driver of gender disparities in cardiac surgery outcomes, according to a new study published in the Journal of the American Heart Association April 9. The…
Chesterfield, Mo.-based Mercy has launched a pilot program to expand access to cardiovascular care for rural patients through a collaboration with Marshall, Ark.-based Boston Mountain Rural Health Center. The initiative connects patients in Northwest Arkansas with Mercy cardiologists via virtual…
Advertisement
Rome, Ga.-based AdventHealth Redmond has opened a new Heart, Lung and Vascular Institute, centralizing cardiac services in one location, according to an April 17 report by Coosa Valley News. The 40,000-square-foot facility opened to patients April 20 and offers diagnostic…
Anthony Hilliard, MD, was appointed president of Loma Linda (Calif.) University Health, effective July 1. Dr. Hilliard will succeed Richard Hart, MD, DrPH. He will also continue to serve as CEO of the system’s hospitals, a role he has held…
Wilmington, Del.-based ChristianaCare and Newark-based Cardiovascular Physicians of Delaware have formed a joint venture to open a new cardiovascular-focused ASC in Newark, Del. The nearly 9,000-square-foot facility will provide services including diagnostic heart catheterizations, coronary and peripheral vascular interventions, ablation…
Stereotaxis, an endovascular surgical robotics company, has signed a definitive agreement to acquire Robocath, a cardiology and neurointerventions robotics developer. The acquisition expands Stereotaxis’ portfolio of fully-integrated robotic technologies for electrophysiology, interventional cardiology and neurointerventions, according to an April 15…
Royal Philips has received FDA 510(k) clearance for its Spectral CT Verida system, bringing the company’s AI-powered spectral CT technology to the U.S. The system combines always-on spectral imaging with AI-based reconstruction to support clinical decision-making across applications, including cardiac…